When to institute nutritional support If it remains difficult to define 'clinically significant malnutrition', and there i3 little reliable information from controlled clinical trials, how can the problem of whether or not to institute nutritional support be best tackled? The following factors should influence decision making.
Clinical sequelae of malnutrition
There can be little doubt as a result of a number of epidemiological studies that clinical malnutrition, which can be equated with negative nitrogen balance (Lee, 1979) , has serious clinical sequelae ( Table I ) and knowledge of these should influence decisions about instituting nutritional support. Thus, nutritional deficiency leads to a significant increased susceptibility to infection (Scrimshaw et al. 1959 (Scrimshaw et al. , 1968 (Daly et al. 1972) . It is possible to improve experimentally the 'strength' of intestinal anastomoses with nutritional support (Rolandelli et al. 1985) .
Factors contributing to malnutrition
One of the commonest factors contributing to malnutrition is inadequate intake of nutrients before admission, due to the underlying disease process (e.g. mechanical dysphagia due to a carcinoma of the oesophagus). In two recent controlled trials our patients had received a grossly inadequate diet for 2 and 3 weeks before enteral nutrition was instituted (Jones et al. 1983; Keohane et al. 1983b ). Metabolically, the changes that occur in such patients are synonymous with 'starvation'. A second major factor contributing to malnutrition is the 'injury' sustained (the term 'injury' includes trauma, surgery, sepsis and burns). In very important ways, the metabolic responses to starvation and injury differ (for reviews, see Woolfson, 1979; Silk, 1983) .
(a) The staruedpatient. Here, the metabolic changes are geared to reduce losses of body constituents. Insulin levels fall, glucagon levels rise, the basal metabolic rate (BMR) falls, the hormonal milieu is such that up to 95% of energy production is finally derived from fat (Grande, 1968) and protein mass is spared with N losses falling from 8-10 to 2-4 g/zq h (Woolfson, 1979) . As long as there is no coexisting 'injury' the totally-fasted patient may survive as long as 40-60 d. Why, when and how to feedpatients in hospital ' 5 5 (b) The 'injured' patient. The short (6-8 h) 'ebb' phase of injury is characterized by an increase in catecholamine secretion (Woolfson, 1979) . The purpose is to allow escape to safety and to maintain blood volume. In clinical terms the 'ebb' phase constitutes the immediate post-operative period following surgery, when attention should be paid to achieving haemodynamic stability. The 'flow' phase is the most important period as far as nutritional support is concerned as it is the time when the major metabolic changes geared to meeting increased energy demands occur. The most important aspect of the 'flow' phase is that basal energy requirements increase and the BMR rises. It is thought that this increased demand in energy is met by the hormonal changes which are characterized by increased production of circulating glucagon (Cope et al. 1943) , growth hormone (Ross et al. 1966), cortisol (Cope et al. 1943 ) and insulin. In the case of insulin, however, 'resistance' to its action occurs (Allison et al. 1968) . These changes result in mobilization of adipose triglyceride and breakdown of muscle protein to provide energy from lipolysis, branched-chain amino acid (BCAA) oxidation in muscle and gluconeogenesis. In contrast to energy production in starvation, a maximum of only 80% of energy demands in the injured patient can be derived from fat (Kinney et al. 1970 ); the remainder is met from protein breakdown. It follows that weight loss is marked in response to this increased energy demand and is often as high as 1 . 5 kgl24 h. Recent work shows that this is not only caused by fat and protein breakdown, but also by diminished protein synthesis (O'Keefe et al. 1974) . Moreover the increases in protein breakdown, as well as decreased synthesis, explains why N losses are so high in severe injury.
In the third phase of the metabolic response to injury, the 'anabolic' phase, the hormonal response is reversed, BMR falls and patients can attain positive N balance.
(c) The mixed picture. The metabolic changes in starvation are geared towards conserving energy output, whereas in response to injury the metabolic response is geared towards coping with the increased energy demands and it follows that nutritional requirements will be markedly different.
In practice patients often do not fall simply into one or the other category. Frequently they may suffer injury after a period of undernutrition, e.g. oesophagogastrectomy after a period of starvation due to mechanical dysphagia; chest infection following undernutrition as a consequence of a stroke. While the magnitude of the increased energy requirements in response to injury is governed largely by the size of the injury (Moore, 1959) , the requirements are reduced at any given injury size by previous starvation (Abbott & Albertsen, 1963) .
Natural history of the underlying disease process
In the author's opinion one of the most important aids to deciding whether to institute nutritional support in medical or surgical patients is a knowledge of the natural history of the underlying disease process. Too often nutritional support for the patient is requested too late (e.g. the patient who is considered to have a reversible neurologic defect, but who has been starved for 3-4 weeks) and too often nutritional support is requested inappropriately (e.g. malnutrition developing in the patient with terminal cancer for whom no other form of therapy is indicated).
The role of nutritional support is not just to treat established malnutrition but to prevent its onset (Silk, 1984) . Thus, while it is clear that nutritional support is required in the grossly undernourished patient with treatable underlying disease (Fig. I) , there are grounds in our opinion for providing nutritional support early on in the course of the disease if it is clear that malnutrition would otherwise develop. Nutritional support must be considered as a link in the chain of therapy, buying time for those who are treating the underlying disease process.
Application of nutritional support
If the reader adheres to the philosophy outlined previously, then there will be occasions when almost any medical condition needs inclusion. However, the following medical conditions deserve particular mention.
Short-boeuel syndrome
The natural history of the short-bowel syndrome can be predicted with certainty, and patients will succumb to malnutrition unless they receive nutritional support. Specific aspects of parented and enteral nutrition have been reviewed (Fischer & Freund, 1983; Betzhold & Howard, 1984 
InfEammatory-bowel disease
There is abundant literature on the influence that nutritional support has had on the short-as well as long-term management of inflammatory-bowel disease but it is often impossible to evaluate results because of the absence of control groups. Patients with inflammatory-bowel disease are often malnourished (Driscoll & Rosenberg, 1978) . Many of the reports have therefore been concerned with improvements achieved in nutritional status, usually in combination with bowel rest, and, at the same time, the authors have attempted to draw conclusions about patient outcome, particularly in relation to the avoidance of surgical intervention (Fischer et al. 1973 ). There are, however, problems inherent in the design of experiments involving patients with inflammatory-bowel disease, not only because of the difficulties that occur in reaching a precise diagnosis, but also because of differences in duration, extent and severity of the disease, all of which may affect the response to therapy.
Five important conclusions can be drawn from the information available: (I) nutritional support, administered either by the enteral or parented route, in combination with medical therapy, frequently results in an improvement of the nutritional status of patients with inflammatory-bowel disease (Fischer et (Dickinson et al. 1980 ) which cannot therefore be considered as primary therapy; (3) a recent study (O'Morain et al. 1984) has shown that enteral nutrition using a chemically defined elemental diet, was as effective as corticosteroids in achieving remission in patients with newly diagnosed Crohn's disease. Follow up of the patients was short, however, and the study has not yet been repeated elsewhere; (4) decisions as to whether to recommend surgery in malnourished patients with small intestinal Crohn's disease should not be made until efforts have been made to improve the nutritional status of these patients. This is because there is a strong suggestion from uncontrolled studies that surgery was unnecessary in a significant proportion of patients given nutritional support (Fischer et 
Enterocutaneous fistulas
The introduction of nutritional support has had a major impact on the survival of patients with enteracutaneous fistulas. Overall, mortality was in the region of 4~4 5 % (Edmunds et al. 1960; Chapman et al. 1964 ) and as high as 60% in patients considered malnourished (Edmunds et al. 1960) . Since the introduction of nutritional support, mortality has fallen to between 9 and 347'0 (Sheldon et al. Rossalion, 1978) . The mechanism of action is far from being understood, and controversy exists as to whether nutritional support with bowel rest (i.e. parenteral nutrition) is superior to enteral nutrition using an elemental diet, which can marginally reduce ileostomy output as well as the volume of ileal fistual effluent (Hill et al. 1975 (Hill et al. , 1976 ). Yet again there are no controlled clinical trials to answer this point.
Acute pancreatitis
Patients with acute pancreatitis are a further group who, under certain circumstances, require nutritional support. In 70-80% of patients che abdominal pain and ileus, if present, resolve and introduction of oral feeding is possible, usually within about 5 d or so. These patients do not require further nutritional support.
In about one-fifth of cases (Gliedman et al. 1970) , the pancreatitis persists for longer, or the patients develop haemorrhagic or post-necrotic pancreatitis, or the pancreatitis is complicated by an abscess or pseudocyst function. In these cases, some form of nutritional support is mandatory, particularly since these patients are often hypermetabolic, with N losses in excess of 15 g/d.
It al. 1983 ). In the most recent studies (Horst et al. 1984) , thirty-seven patients in two groups were given increasing amounts of diets based either on dietary protein or a BCAA-enriched amino acid solution. Both groups of patients attained positive N balance, but encephalopathy was induced significantly less frequently in the group receiving the BCAA-enriched diet: this may be a significant advance in the nutritional management of these difficult patients. 
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